Post by
Kherson on Feb 29, 2024 7:15pm
Chemours Suspends Top Executives
In securities filings Thursday morning, Chemours said it is looking into reports made to its ethics hotline, how the company managed working capital, and how that in turn affected incentive compensation plans and custom metrics reported to investors and the Securities and Exchange Commission.
Chemours shares fell more than 35% Thursday after the company said it was putting its top executives on leave and delaying its audited financial filings amid an internal investigation into its bookkeeping, compensation and ethics-hotline reports
The company said it put Chief Executive Mark Newman on leave, as well as Chief Financial Officer Jonathan Lock and its chief accounting officer, Camela Wisel.
WSJ
Let's not forget as I have clearly pointed out, that Chemtrade in the past used bogus contractor injury rates to justify executive compensation plans...
It might now be a good time to pass that info on to the SEC!
Kherson
Comment by
Red_Deer on Mar 01, 2024 5:46am
""It might now be a good time to pass that info on to the SEC"" Hey KHERSON__Chemtrade trading ONLY on the PINK SHEETS Means that the SEC do NOT have ANY Regulatory Reporting Requirements__Thus Reporting to the SEC about Chemtrade is NOT POSSIBLE.
Comment by
Red_Deer on Mar 01, 2024 12:32pm
Hey Kherson__Another RED HERRING eh !!!! As Chemtrade trades ONLY on the US PINK SHEETS__SEC does NOT Have ANY Regulatory OverSight.
Comment by
Janniem on Mar 01, 2024 4:46pm
Chemours news has absolutely nothing to do with Chemtrade. Not sure why it merits a discussion on this board under Chemtrade. I am happy to collect the dividend and happy to pick up more stock. It's a win win for me. Even though my stock when down significantly I am picking up more and it will be about six months before I earn my dollars back in distributions.